These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9856695)

  • 21. Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients.
    Sorraritchingchai S; Thongprasert S; Charoentum C; Chewasakulyong B; Moonprakan S
    J Med Assoc Thai; 2004 Apr; 87(4):367-71. PubMed ID: 15217171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
    Kubota K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
    Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
    Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer.
    Jones SF; Burris HA
    Ann Pharmacother; 1996 May; 30(5):501-6. PubMed ID: 8740332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature.
    Devlin JG; Langer CJ
    Clin Lung Cancer; 2007 Mar; 8(5):319-26. PubMed ID: 17562231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vinorelbine for non-small cell lung cancer.
    Piccirillo MC; Daniele G; Di Maio M; Bryce J; De Feo G; Del Giudice A; Perrone F; Morabito A
    Expert Opin Drug Saf; 2010 May; 9(3):493-510. PubMed ID: 20350282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of factors associated with quality of life for patients with non-small lung cancer receiving outpatient vinorelbine therapy as alternative inpatient therapy].
    Ishiura Y; Terasaki Y; Yamamoto H; Yokawa S; Fukushima W; Hirosawa H; Izumi R; Tanikawa F; Maruyama K; Ichihashi K; Miyazu M; Yoneda K; Kasahara K; Fujimura M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1401-4. PubMed ID: 17876137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.
    Gralla RJ; Gatzemeier U; Gebbia V; Huber R; O'Brien M; Puozzo C
    Drugs; 2007; 67(10):1403-10. PubMed ID: 17600389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A trial with single-agent vinorelbine in taxane-resistant non-small cell lung cancer].
    Miyata J; Sano T; Bando H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):239-42. PubMed ID: 11242654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vinorelbine--a clinical review.
    Gregory RK; Smith IE
    Br J Cancer; 2000 Jun; 82(12):1907-13. PubMed ID: 10864196
    [No Abstract]   [Full Text] [Related]  

  • 32. New directions for chemotherapy in non-small-cell lung cancer.
    Green MR
    Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
    Kudoh S; Takeda K; Nakagawa K; Takada M; Katakami N; Matsui K; Shinkai T; Sawa T; Goto I; Semba H; Seto T; Ando M; Satoh T; Yoshimura N; Negoro S; Fukuoka M
    J Clin Oncol; 2006 Aug; 24(22):3657-63. PubMed ID: 16877734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC.
    Evans WK
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 4):18-25; discussion 25-6. PubMed ID: 9556779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of economic analysis of Le Chevalier Vinorelbine Study.
    Hillner BE; Smith TJ
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 4):14-6; discussion 17. PubMed ID: 9556778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer.
    Berrieman HK; Cawkwell L; O'Kane SL; Smith L; Lind MJ
    Oncol Rep; 2006 Jan; 15(1):283-6. PubMed ID: 16328069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overdosage of vinorelbine in a woman with metastatic non-small-cell lung carcinoma.
    Lotz JP; Chapiro J; Voinea A; Cornu P; Péne F; Bazelly B; Similowski T; Derquenne F
    Ann Oncol; 1997 Jul; 8(7):714-5. PubMed ID: 9296231
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
    Bartsch V
    Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival.
    Lilenbaum RC; Langenberg P; Dickersin K
    Cancer; 1998 Jan; 82(1):116-26. PubMed ID: 9428487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.